Compile Data Set for Download or QSAR
Found 13 Enz. Inhib. hit(s) with Target = 'Tyrosine-protein kinase BTK' and Ligand = 'BDBM230089'
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Bristol-Myers Squibb Company

US Patent
LigandPNGBDBM230089(US10106559, Example 12 | US10435415, Example 12 | ...)copy SMILEScopy InChI
Affinity DataIC50: 0.400nMAssay Description:To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), A...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q27S7R2CUS Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Bristol-Myers Squibb Company

US Patent
LigandPNGBDBM230089(US10106559, Example 12 | US10435415, Example 12 | ...)copy SMILEScopy InChI
Affinity DataIC50: 0.400nMAssay Description:To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), A...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2C53P6VUS Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Bristol-Myers Squibb Company

US Patent
LigandPNGBDBM230089(US10106559, Example 12 | US10435415, Example 12 | ...)copy SMILEScopy InChI
Affinity DataIC50: 0.400nMpH: 7.4 T: 2°CAssay Description:To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BK1B6SUS Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Bristol-Myers Squibb Company

US Patent
LigandPNGBDBM230089(US10106559, Example 12 | US10435415, Example 12 | ...)copy SMILEScopy InChI
Affinity DataIC50: 0.400nMpH: 7.4 T: 2°CAssay Description:To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), A...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2SF2Z7QUS Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Bristol-Myers Squibb Company

US Patent
LigandPNGBDBM230089(US10106559, Example 12 | US10435415, Example 12 | ...)copy SMILEScopy InChI
Affinity DataIC50: 1.10nMpH: 7.4 T: 2°CAssay Description:To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), A...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2SF2Z7QUS Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Bristol-Myers Squibb Company

US Patent
LigandPNGBDBM230089(US10106559, Example 12 | US10435415, Example 12 | ...)copy SMILEScopy InChI
Affinity DataIC50: 1.10nMAssay Description:To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), A...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q27S7R2CUS Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Bristol-Myers Squibb Company

US Patent
LigandPNGBDBM230089(US10106559, Example 12 | US10435415, Example 12 | ...)copy SMILEScopy InChI
Affinity DataIC50: 1.10nMAssay Description:To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), A...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2C53P6VUS Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Bristol-Myers Squibb Company

US Patent
LigandPNGBDBM230089(US10106559, Example 12 | US10435415, Example 12 | ...)copy SMILEScopy InChI
Affinity DataIC50: 1.80nMpH: 7.4 T: 2°CAssay Description:To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), A...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2SF2Z7QUS Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Bristol-Myers Squibb Company

US Patent
LigandPNGBDBM230089(US10106559, Example 12 | US10435415, Example 12 | ...)copy SMILEScopy InChI
Affinity DataIC50: 1.80nMAssay Description:To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), A...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q27S7R2CUS Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Bristol-Myers Squibb Company

US Patent
LigandPNGBDBM230089(US10106559, Example 12 | US10435415, Example 12 | ...)copy SMILEScopy InChI
Affinity DataIC50: 1.80nMAssay Description:To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), A...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2C53P6VUS Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Bristol-Myers Squibb Company

US Patent
LigandPNGBDBM230089(US10106559, Example 12 | US10435415, Example 12 | ...)copy SMILEScopy InChI
Affinity DataIC50: 2.10nMAssay Description:To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), A...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2C53P6VUS Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Bristol-Myers Squibb Company

US Patent
LigandPNGBDBM230089(US10106559, Example 12 | US10435415, Example 12 | ...)copy SMILEScopy InChI
Affinity DataIC50: 2.10nMpH: 7.4 T: 2°CAssay Description:To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), A...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2SF2Z7QUS Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Bristol-Myers Squibb Company

US Patent
LigandPNGBDBM230089(US10106559, Example 12 | US10435415, Example 12 | ...)copy SMILEScopy InChI
Affinity DataIC50: 2.10nMAssay Description:To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), A...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q27S7R2CUS Patent